Adaptimmune Therapeutics PLC

ADAPYOTC· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$178.0M

▲ 195.3% YoY

Net Income

-$70.8M

▲ 37.8% YoY

EPS

$-0.05

▲ 44.4% YoY

Cash

$91.1M

▼ 36.7% YoY

FY 2024 · As of 2024-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.